Company Overview

AIM IMMUNOTECH INC.

AIM
Annual
Revenue vs. Cost of Revenue
Revenue Cost of Revenue
Total Operating Expenses vs. Operating Income
Total Operating Expenses Operating Income
Net Income
Net Income
Revenue
0M
2025 FY
Net Income
-14M
2025 FY
Shares Outstanding
2M
2025 FY
EPS
-8.62USD
2025 FY
Company Information
SIC Code
2836
CIK Code
946644
Exchange
NYSE
Location
US